Erythromycin and its derivatives; salts thereof
HS-Code 294150Supply Chain Analysis
51 entities · 2024 · exports
Source Countries
Trade Value
Total Quantity
Avg per Entity
Top 5 Concentration
Value Distribution (Top 5)
Efficiency Quadrant — Unit Price vs Order Value
Premium · Volume Player · Niche · Weak
China
$0.30B
64.97% share
India
$0.10B
21.69% share
European Union
$0.02B
4.78% share
Few dominant players — high dependency risk.
Share Split
Top Exporting Countries
| # | Country | Share | Value | 1Y Growth | 3Y Growth | Signal |
|---|---|---|---|---|---|---|
| 1 | 64.97% | $0.30B | +9.75% | +85.62% | 🐢 Slowing | |
| 2 | 21.69% | $0.10B | -12.97% | +15.26% | ⚠ Momentum Lost | |
| 3 | European Union | 4.78% | $0.02B | +2.77% | +26.80% | 🐢 Slowing |
| 4 | 1.62% | $0.01B | +21.85% | +35.24% | 🐢 Slowing | |
| 5 | 1.41% | $0.01B | -34.51% | -5.45% | 📉 Sustained Drop |
Value vs YoY Growth
Bubble size = market share · Right + Up = high value, high growth
Demand Market Analysis
102 entities · 2024 · imports
Buyer Countries
Trade Value
Total Quantity
Avg per Entity
Top 5 Concentration
Value Distribution (Top 5)
Efficiency Quadrant — Unit Price vs Order Value
Premium · Volume Player · Niche · Weak
India
$0.16B
33.77% share
Japan
$0.04B
8.52% share
Croatia
$0.03B
5.43% share
Few dominant players — high dependency risk.
Share Split
Global Trade Map
Exports + Imports by country (hover for details)
Explore more products
Access full trade data across our entire product database.
Have an account? Sign in